BMP9 as a potential biomarker for dalantercept efficacy against ALK1-mediated angiogensis in head and neck cancer

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2012
This article has no abstract
Epistemonikos ID: 2b92ff6581392f0ba670bfc6316273f48d4d44d5
First added on: Feb 05, 2025